Ftse Mib
38.456,17
0,09%
DAX
22.425,93
0,73%
S&P 500
5.983,25
-0,50%
NASDAQ
19.286,92
-1,21%
Bitcoin
92.583,27
-3,83%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Equillium Inc (EQ) Equillium Inc (EQ) Notizie

Equillium Inc

EQ
0,8003
-0,0797 (-9,06%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:29:40
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/2/202501:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202501:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202501:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202514:01EDGAR2Form 8-K - Current report
06/2/202514:00BWEquillium Announces Positive Data from Phase 2 Study..
07/1/202500:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202500:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202422:04EDGAR2Form 8-K - Current report
12/12/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202422:10EDGAR2Form 8-K - Current report
15/11/202403:50EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202422:05EDGAR2Form 8-K - Current report
13/11/202422:01BWEquillium Reports Third Quarter 2024 Financial Results and..
13/11/202414:00BWEquillium to Present at the Stifel Healthcare Conference
12/11/202414:00BWEquillium Announces Poster Presentation at the Society for..
31/10/202417:19EDGAR2Form 144 - Report of proposed sale of securities
31/10/202412:05EDGAR2Form 8-K - Current report
31/10/202412:00BWEquillium Maintains Rights to Itolizumab Following Ono..
31/10/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202414:00BWEquillium Announces Abstract Accepted for Poster..
18/9/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202414:00BWEquillium to Present at the Stifel Virtual Inflammation &..
04/9/202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
28/8/202414:00BWEquillium to Present at the Wells Fargo Healthcare..
08/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:01BWEquillium Reports Second Quarter 2024 Financial Results and..
06/8/202414:00BWEquillium Announces Positive Interim Analysis from Phase 3..
23/7/202422:01EDGAR2Form 8-K - Current report
18/7/202420:08EDGAR2Form 8-K - Current report
18/7/202419:57BWEquillium Announces Second Quarter 2024 Estimated Cash and..
02/7/202414:00BWEquillium to Participate in Upcoming Investor Conferences
12/6/202414:00BWEquillium to be included in the Russell Microcap® Index
05/6/202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
04/6/202414:00EDGAR2Form 8-K - Current report
04/6/202414:00BWEquillium Announces Positive Topline Data from Phase 2 Study..
29/5/202414:00BWEquillium to Present at the Jefferies Global Healthcare..
23/5/202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202423:00EDGAR2Form 8-K - Current report
14/5/202414:00BWEquillium Announces Interim Enrollment Achieved in Phase 3..
09/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:01BWEquillium Reports First Quarter 2024 Financial Results and..
07/5/202414:00BWEquillium Announces Poster Presentation at the Annual..
03/4/202414:00BWEquillium Reports Inducement Grant Under Nasdaq Listing Rule..
01/4/202414:00BWEquillium Announces Positive Topline Data from the Type B..
25/3/202421:01BWEquillium Reports on Fourth Quarter and Full Year 2023..
22/3/202413:00BWEquillium to Present at the H.C. Wainwright Autoimmune &..
08/3/202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: 0,86 Min: 0,7802 Max: 0,8646
Chiusura: 0,88

La tua Cronologia

NASDAQ
EQ
Equillium
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci